Class IIOngoingD-0356-2021
Drug recall · April 28, 2021
Flurandrenolide Ointment USP recall
Why: Failed Impurities/Degradation Specifications:
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Flurandrenolide Ointment USP, 0.05%, Net Wt. 60 grams, Rx Only, Teligent Pharma, Inc. Buena, New Jersey 08310 NDC 52565-017-60
- Lots / codes
Lot #13974 EXP 7/2021
- Quantity
- 3432 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- Distributed Nationwide in the USA
- Initiated
- April 9, 2021 · Voluntary: Firm initiated
- Classified
- April 28, 2021
- Reported
- April 28, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Flurandrenolide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.